Photo courtesy of Mylan
30 January 2017Americas

Mylan enjoined from bringing Lialda generic to market

Mylan's plans to bring a generic version of Shire's bowel disease drug Lialda (mesalamine) to market were shut down when a  district court judge held that the action would infringe Shire's patent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at